Form 8-K - Current report:
SEC Accession No. 0001193125-24-256062
Filing Date
2024-11-12
Accepted
2024-11-12 16:52:03
Documents
15
Period of Report
2024-11-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d812587d8k.htm   iXBRL 8-K 45499
2 EX-3.1 d812587dex31.htm EX-3.1 7794
  Complete submission text file 0001193125-24-256062.txt   244368

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blacu-20241112.xsd EX-101.SCH 4878
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacu-20241112_def.xml EX-101.DEF 15729
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacu-20241112_lab.xml EX-101.LAB 26865
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacu-20241112_pre.xml EX-101.PRE 16958
17 EXTRACTED XBRL INSTANCE DOCUMENT d812587d8k_htm.xml XML 9322
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 241449410
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)